# Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers

> **NCT01135017** · PHASE4 · TERMINATED · sponsor: **Sanofi** · enrollment: 112 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Dronedarone
- **DRUG:** Placebo (for Dronedarone)

## Key facts

- **NCT ID:** NCT01135017
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2013-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01135017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01135017, "Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01135017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*